HuGE Literature Finder
Records
1
-
4
Carboxylesterase 1 polymorphisms are associated with clinical outcomes in gastroenteric cancer patients treated with capecitabine. Cancer chemotherapy and pharmacology 2021 Feb . Liu Duo, Li Xuehua, Li Xiang, Wang Huiqi, Dong M |
Impact of DPYD, DPYS, and UPB1 gene variations on severe drug-related toxicity in patients with cancer. Cancer science 2020 Jul . Yokoi Katsuyuki, Nakajima Yoko, Matsuoka Hiroshi, Shinkai Yasuko, Ishihara Takuma, Maeda Yasuhiro, Kato Takema, Katsuno Hidetoshi, Masumori Koji, Kawada Kenji, Yoshikawa Tetsushi, Ito Tetsuya, Kurahashi Hiro |
Preliminary Evidence for Enhanced Thymine Absorption: A Putative New Phenotype Associated With Fluoropyrimidine Toxicity in Cancer Patients. Therapeutic drug monitoring 2018 May . Duley John A, Ni Ming, Shannon Catherine, Norris Ross L, Sheffield Leslie, Cowley David, Harris Marion, van Kuilenburg André B P, Helsby Nuala, George Rani, Charles Bruce |
Contribution of dihydropyrimidinase gene alterations to the development of serious toxicity in fluoropyrimidine-treated cancer patients. Cancer chemotherapy and pharmacology 2010 Mar 65 (4): 661-9. Fidlerova Julie, Kleiblova Petra, Bilek Matej, Kormunda Stanislav, Formankova Zuzana, Novotny Jan, Kleibl Zden |
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 10, 2022
- Content source: